Home/Filings/4/0001387131-20-002255
4//SEC Filing

SULLIVAN GREGORY M 4

Accession 0001387131-20-002255

CIK 0001430306other

Filed

Feb 26, 7:00 PM ET

Accepted

Feb 27, 4:23 PM ET

Size

7.8 KB

Accession

0001387131-20-002255

Insider Transaction Report

Form 4
Period: 2020-02-25
SULLIVAN GREGORY M
Chief Medical Officer
Transactions
  • Award

    Stock Option

    2020-02-25+39,00039,000 total
    Exercise: $0.40From: 2021-02-25Exp: 2030-02-25Common Stock (39,000 underlying)
  • Award

    Stock Option

    2020-02-25+39,00039,000 total
    Exercise: $0.50From: 2021-02-25Exp: 2030-02-25Common Stock (39,000 underlying)
Footnotes (2)
  • [F1]The option vests 1/3rd on the first anniversary of issuance and 1/36th each month thereafter for 24 months.
  • [F2]The option was granted pursuant to the Issuer's 2020 Stock Incentive Plan.

Issuer

Tonix Pharmaceuticals Holding Corp.

CIK 0001430306

Entity typeother

Related Parties

1
  • filerCIK 0001610106

Filing Metadata

Form type
4
Filed
Feb 26, 7:00 PM ET
Accepted
Feb 27, 4:23 PM ET
Size
7.8 KB